Risk-reducing surgery in BRCA 1/2 mutation carries: a point of view

por De Felice, Francesca, Marchetti, Claudia
Publicado 2015

First-line treatment of women with advanced ovarian cancer: focus on bevacizumab

por Marchetti, Claudia, Muzii, Ludovico, Romito, Alessia, Benedetti Panici, Pierluigi
Publicado 2019

Immunotherapy in cervical cancer: the advent of precision medicine

por De Felice, Francesca, Marchetti, Claudia, Fagotti, Anna, Scambia, Giovanni
Publicado 2020

Treatment of recurrent epithelial ovarian cancer

por Pisano, Carmela, Bruni, Giovanni S, Facchini, Gaetano, Marchetti, Claudia, Pignata, Sandro
Publicado 2009

Defective DNA repair mechanisms in prostate cancer: impact of olaparib

por De Felice, Francesca, Tombolini, Vincenzo, Marampon, Francesco, Musella, Angela, Marchetti, Claudia
Publicado 2017

Late aortic lymphocele and residual ovary syndrome after gynecological surgery

por Pastore, Maria, Manci, Natalina, Marchetti, Claudia, Esposito, Francesca, Iuliano, Marialetizia, Manganaro, Lucia, Panici, Pierluigi Benedetti
Publicado 2007

An Unexpected Complete Remission of Advanced Intestinal-Type Vulvar Adenocarcinoma after Neoadjuvant Chemotherapy: A Case Report and a Literature Review

por Musella, Angela, Marchetti, Claudia, Salerno, Laura, Vertechy, Laura, Iadarola, Roberta, Pecorella, Irene, Panici, Pierluigi Benedetti
Publicado 2013

A commentary on the discrepancy between blood and tumour BRCA testing: An open question

por De Paolis, Elisa, Marchetti, Claudia, Concolino, Paola, Scambia, Giovanni, Urbani, Andrea, Fagotti, Anna, Minucci, Angelo
Publicado 2022

The prognostic role of systemic inflammatory markers in apparent early-stage ovarian cancer

por Bizzarri, Nicolò, D’Indinosante, Marco, Marchetti, Claudia, Tudisco, Riccardo, Turchiano, Francesca, Scambia, Giovanni, Fagotti, Anna
Publicado 2022

Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors

por De Felice, Francesca, Marchetti, Claudia, Palaia, Innocenza, Musio, Daniela, Muzii, Ludovico, Tombolini, Vincenzo, Panici, Pierluigi Benedetti
Publicado 2015

Evolution of Clinical Trials in Ovarian Cancer Management over the Past 20 Years: Never Settle Down, Always Go Beyond

por De Felice, Francesca, Vertechy, Laura, Giudice, Elena, Ergasti, Raffaella, Boccia, Serena, Fagotti, Anna, Scambia, Giovanni, Marchetti, Claudia
Publicado 2021

Multiple Bulky Lymph Nodal Metastasis in Microinvasive Cervical Cancer: A Case Report and Literature Review

por Marchetti, Claudia, Manci, Natalina, Pernice, Milena, Di Tucci, Chiara, Carraro, Carlo, Burratti, Moira, Giorgini, Margherita, Benedetti Panici, Pierluigi
Publicado 2010

Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers

por Marchetti, Claudia, De Felice, Francesca, Palaia, Innocenza, Perniola, Giorgia, Musella, Angela, Musio, Daniela, Muzii, Ludovico, Tombolini, Vincenzo, Panici, Pierluigi Benedetti
Publicado 2014

Weekly versus three weeks chemotherapy for advanced ovarian cancer: a meta-analysis

por Marchetti, Claudia, De Felice, Francesca, Musella, Angela, Palaia, Innocenza, Monti, Marco, Musio, Daniela, Muzii, Ludovico, Tombolini, Vincenzo, Panici, Pierluigi Benedetti
Publicado 2016

Tumor BRCA testing in ovarian cancer and EQA scheme: our experience of a critical evaluation

por De Paolis, Elisa, Concolino, Paola, Onori, Maria Elisabetta, Santonocito, Concetta, Marchetti, Claudia, Fagotti, Anna, Scambia, Giovanni, Urbani, Andrea, Minucci, Angelo
Publicado 2021

ToleRability of BevacizUmab in elderly Ovarian cancer patients (TURBO study): a case-control study of a real-life experience

por Amadio, Giulia, Marchetti, Claudia, Villani, Emanuele Rocco, Fusco, Domenico, Stollagli, Francesca, Bottoni, Carolina, Distefano, Mariagrazia, Colloca, Giuseppe, Scambia, Giovanni, Fagotti, Anna
Publicado 2019

Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients

por Buttarelli, Marianna, Ciucci, Alessandra, Palluzzi, Fernando, Raspaglio, Giuseppina, Marchetti, Claudia, Perrone, Emanuele, Minucci, Angelo, Giacò, Luciano, Fagotti, Anna, Scambia, Giovanni, Gallo, Daniela
Publicado 2022

NLR and BRCA mutational status in patients with high grade serous advanced ovarian cancer

por Marchetti, Claudia, D’Indinosante, Marco, Bottoni, Carolina, Di Ilio, Chiara, Di Berardino, Stefano, Costantini, Barbara, Minucci, Angelo, Vertechy, Laura, Scambia, Giovanni, Fagotti, Anna
Publicado 2021

Efficacy and toxicity of bevacizumab in recurrent ovarian disease: an update meta-analysis on phase III trials

por Marchetti, Claudia, De Felice, Francesca, Palaia, Innocenza, Musella, Angela, Di Donato, Violante, Gasparri, Maria Luisa, Musio, Daniela, Muzii, Ludovico, Tombolini, Vincenzo, Panici, Pierluigi Benedetti
Publicado 2015

PI3K/AKT/mTOR Pathway in Ovarian Cancer Treatment: Are We on the Right Track?

por Gasparri, Maria Luisa, Bardhi, Erlisa, Ruscito, Ilary, Papadia, Andrea, Farooqi, Ammad Ahmad, Marchetti, Claudia, Bogani, Giorgio, Ceccacci, Irene, Mueller, Michael D., Benedetti Panici, Pierluigi
Publicado 2017